Harvard Health Letter

In Brief: Good news about new macular degeneration drugs

A study of two drugs used to treat macular degeneration found no added risk of heart disease or death compared to older treatments.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In